Peptide Therapy TB-500
Provider evaluation · Appropriate testing · Ongoing monitoring
TB-500 Is Not Thymosin Beta-4
TB-500 is a synthetic peptide corresponding to a short region of thymosin beta-4, a protein the body produces and concentrates at sites of injury. The two names get used interchangeably online, which is where most of the confusion starts. They are related, but they are not the same molecule. Thymosin beta-4 is the body's most abundant actin-binding protein, and actin governs how cells change shape and move. That is the mechanism most of the research attention follows: cell migration, tissue flexibility, and how quickly cells reach the place where repair is happening. Nearly all of that work is preclinical. Large human trials do not exist. T Clinics USA treats that gap honestly. A provider reviews what is actually going on, decides whether TB-500 belongs in a plan at all, and monitors what follows through virtual and in-clinic care across three Florida locations. If it does not, that is a useful answer too.
A Medical Process Designed to Reduce Guesswork
No dramatic promises and no treatment based on symptoms alone. T Clinics USA combines medical evaluation, lab-guided decisions and ongoing follow-up so each patient can make an informed decision.
How It Works






